Gelteq (GELS) Receivables - Net (2023 - 2025)
Gelteq (GELS) posted quarterly Receivables - Net of $272331.8 for Q4 2025, up 36.53% year-over-year from $199461.3 in Q4 2024, and down 7.5% quarter-over-quarter from $294422.5 in Q2 2025.
Gelteq (GELS) Receivables - Net (2023 - 2025) Analysis & Trends
Gelteq's Receivables - Net history runs 3 years deep, the most recent figure standing at $272331.8 for Q4 2025.
- In Q4 2025, Receivables - Net rose 36.53% year-over-year to $272331.8; the TTM figure through Dec 2025 stood at $272331.8 (up 36.53% YoY), while the FY2025 annual figure was $294422.5, up 144.12% from the prior year.
- Receivables - Net for Q4 2025 stood at $272331.8, down from $294422.5 in the prior quarter.
- The five-year high for Receivables - Net was $294422.5 in Q2 2025, with the low at $120604.8 in Q2 2024.
- The 3-year median for Receivables - Net is $230778.8 (2023), against an average of $223519.9.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net slumped 47.74% in 2024, then surged 144.12% in 2025.
- Gelteq's Receivables - Net stood at $230778.8 in 2023, then decreased by 13.57% to $199461.3 in 2024, then soared by 36.53% to $272331.8 in 2025.
- Business Quant data shows GELS's Receivables - Net at $272331.8 in Q4 2025, $294422.5 in Q2 2025, and $199461.3 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Gelteq | 5.85 Mn | 5.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 272,331.77 |
| Dec 31, 2025 | 272,331.77 |
| Jun 30, 2025 | 294,422.51 |
| Jun 30, 2025 | 294,422.51 |
| Dec 31, 2024 | 199,461.34 |
| Dec 31, 2024 | 199,461.34 |
| Jun 30, 2024 | 120,604.78 |
| Jun 30, 2024 | 120,604.78 |
| Jun 30, 2023 | 230,778.85 |
| Jun 30, 2023 | 230,778.85 |